Literature DB >> 6430210

Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis.

D Meek, L S Wolfe, E Andermann, F Andermann.   

Abstract

A 10-year-old boy developed progressive dystonia and dementia. His symptoms had begun at age 2 1/2 years, and he had been unable to walk by 8 years. At age 10 he was severely dystonic, unable to use his hands to feed himself, and almost anarthric . He had dysphagia and urinary incontinence, and functioned at a 4-year-old level of mental development. The mean percentages of beta-hexosaminidase A measured in serum, leukocytes, and fibroblasts by the heat denaturation method, each on three separate assays, were 5.9, 9.8, and 13.0%, respectively. These values are higher than in Tay-Sachs disease but are similar to levels seen in late-onset or adult cases of GM2 gangliosidosis. This patient appears to represent a new phenotype of juvenile GM2 gangliosidosis having dystonia as the dominant symptom.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6430210     DOI: 10.1002/ana.410150408

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Hallervorden-Spatz disease: clinical and MRI study of 11 cases diagnosed in life.

Authors:  L Angelini; N Nardocci; V Rumi; C Zorzi; L Strada; M Savoiardo
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

Review 2.  The natural history of juvenile or subacute GM2 gangliosidosis: 21 new cases and literature review of 134 previously reported.

Authors:  Gustavo H B Maegawa; Tracy Stockley; Michael Tropak; Brenda Banwell; Susan Blaser; Fernando Kok; Roberto Giugliani; Don Mahuran; Joe T R Clarke
Journal:  Pediatrics       Date:  2006-10-02       Impact factor: 7.124

3.  Neurophysiological study in chronic GM2 gangliosidosis (hexosaminidase A and B deficiency), with motor neuron disease phenotype.

Authors:  M Mondelli; A Rossi; S Palmeri; N Rizzuto; A Federico
Journal:  Ital J Neurol Sci       Date:  1989-08

4.  Hexosaminidase A deficiency presenting as juvenile progressive dystonia.

Authors:  R J Hardie; E P Young; J A Morgan-Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-03       Impact factor: 10.154

5.  Neurodegeneration with Progressive Dystonia: Juvenile-Onset Tay-Sachs Disease.

Authors:  Jasmine Kaur; Singanamalla Bhanudeep; Ramprabhu G Suresh; Arushi G Saini; Vikas Bhatia
Journal:  Ann Indian Acad Neurol       Date:  2022-05-17       Impact factor: 1.714

6.  GM2-ganglioside metabolism in hexosaminidase A deficiency states: determination in situ using labeled GM2 added to fibroblast cultures.

Authors:  S S Raghavan; A Krusell; J Krusell; T A Lyerla; E H Kolodny
Journal:  Am J Hum Genet       Date:  1985-11       Impact factor: 11.025

7.  Familial dystonia and visual failure with striatal CT lucencies.

Authors:  C D Marsden; A E Lang; N P Quinn; W I McDonald; A Abdallat; S Nimri
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-05       Impact factor: 10.154

Review 8.  Classification of Dystonia.

Authors:  Lazzaro di Biase; Alessandro Di Santo; Maria Letizia Caminiti; Pasquale Maria Pecoraro; Vincenzo Di Lazzaro
Journal:  Life (Basel)       Date:  2022-01-29

9.  An insight into the biochemistry of inborn errors of metabolism for a clinical neurologist.

Authors:  Rita Christopher; Bindu P Sankaran
Journal:  Ann Indian Acad Neurol       Date:  2008-04       Impact factor: 1.383

10.  The Spectrum of Movement Disorders in Childhood-Onset Lysosomal Storage Diseases.

Authors:  Darius Ebrahimi-Fakhari; Clara Hildebrandt; Peter E Davis; Lance H Rodan; Irina Anselm; Olaf Bodamer
Journal:  Mov Disord Clin Pract       Date:  2017-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.